| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/14/2007 | US20070134153 Lipid-based drug delivery systems against parasitic infections |
| 06/14/2007 | DE102006051512A1 Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin Pharmaceutical compositions medication with cyclosporine |
| 06/14/2007 | CA2632635A1 Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 06/13/2007 | EP1795588A1 Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| 06/13/2007 | EP1795204A1 Functional composition or food containing whey protein, antibody derived from milk, or antibody |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1794164A2 Bridged piperazine and piperidine derivatives as ccr1 antagonists |
| 06/13/2007 | EP1793857A2 Combination therapy with anti-ctla4 and anti-4-1bb antibodies |
| 06/13/2007 | EP1793856A2 Methods and compositions for treating allergic inflammation |
| 06/13/2007 | EP1793848A1 Method for determining dosage for an oral killed vaccine |
| 06/13/2007 | EP1793846A1 Compositions and methods comprising vitamin b12 and an impdh inhibitor for treating viral, inflammatory and proliferative diseases |
| 06/13/2007 | EP1793833A1 Multiple sclerosis treatment |
| 06/13/2007 | EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/13/2007 | EP1357944B1 Perylenequinones for use with immunotherapy agents |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1326611B1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1244690B1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1069909B1 Conjugate vaccines for the prevention of dental caries |
| 06/13/2007 | EP1012304B1 Component of bromelain |
| 06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/13/2007 | EP0986572B2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 06/13/2007 | EP0889972B1 Use of the determination of polymorphims in the promoter region of the TGF-beta 1 gene in diagnosis |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | CN1980937A Thienopyridone carboxamides and their medical use |
| 06/13/2007 | CN1980697A Preventing autoimmune disease by using anti-CD20 antibody |
| 06/13/2007 | CN1977967A Injection preparation and use |
| 06/13/2007 | CN1977962A Leech nutrient liquid and its preparing method |
| 06/13/2007 | CN1977916A Chinese medicine composition for treating skin disease |
| 06/13/2007 | CN1977892A Method for regulating baicalin and baicalein ratio in scutellariae root extract |
| 06/13/2007 | CN1977873A Epimedium total flavone extracting process |
| 06/13/2007 | CN1977855A Medicinal composition containing mangiferin and its preparing method |
| 06/13/2007 | CN1977832A Novel sterile powder injection containing sodium new houttuyfonate orits receivable salt or derivative |
| 06/13/2007 | CN1977674A Pseudo-ginseng water |
| 06/13/2007 | CN1977669A Flavone health-care drink product |
| 06/13/2007 | CN1977667A Method for preparing health-care nutrient powder |
| 06/13/2007 | CN1977662A New use of Chinese angelica, ginger mutton soup |
| 06/13/2007 | CN1977633A Pig's feed pre-mixing material and preparing method |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 06/13/2007 | CN1321106C New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 06/13/2007 | CN1320917C Dripping pills of 'Xiao Chaihu' |
| 06/13/2007 | CN1320889C Compound saline algae capsule |
| 06/13/2007 | CN1320865C Health care food for regulating immunity, antioxidation and its preparing method |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230084 Therapeutic using a bispecific antibody |
| 06/12/2007 | US7230079 purified anti-allergic royal jelly protein; foods, cosmetics, pharmaceuticals |
| 06/12/2007 | US7230078 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230029 Fatty acid analogues for the treatment of proliferative skin disorders |
| 06/12/2007 | US7230021 Therapy for immunology sensitive disease; marine animal extract |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229985 2-(1-isopropoxy-carbonyloxy-2-methylpropyl)-7, 8-dimethoxy-4(5H), 10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine having a solubility of 15-20 mu g/mL in a 1 wt % methylcellulose solution at 37 degrees and a polymer, especially methylcellulose and/or hydroxypropylmethylcellulose. |
| 06/12/2007 | US7229978 Chloromethylating an alcohol or phenol, especially camptothecin, propofol, etoposide, vitamin E, or cyclosporin A, and reacting the product with phosphoric acid in the presence of a base in a suitable polar aprotic solvent |
| 06/12/2007 | US7229969 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 06/12/2007 | US7229809 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229624 Ordered molecular presentation of antigens, method of preparation and use |
| 06/12/2007 | US7229621 Method to enhance the immunogenicity of an antigen |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2214649C Antigen presenting system and methods for activation of t-cells |
| 06/12/2007 | CA2076839C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
| 06/12/2007 | CA2057828C Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines |
| 06/09/2007 | CA2566267A1 Thymidylate kinase mutants and uses thereof |
| 06/07/2007 | WO2007065167A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 06/07/2007 | WO2007064244A1 Medicinal agent |
| 06/07/2007 | WO2007064208A1 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
| 06/07/2007 | WO2007063935A1 Aromatic compound |
| 06/07/2007 | WO2007063934A1 Alicyclic heterocyclic compound |
| 06/07/2007 | WO2007063010A1 Novel vinylogous acids derivatives |
| 06/07/2007 | WO2007062817A1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position |
| 06/07/2007 | WO2007062459A1 Selective kinase inhibitors based on pyridine scaffold |
| 06/07/2007 | US20070130629 Renal Regulatory Elements and Methods of Use Thereof |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070129289 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128701 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/07/2007 | US20070128698 Peptide constructs for treating autoimmune and related diseases |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128212 Ceramidase inhibitor |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
| 06/07/2007 | US20070128197 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 06/07/2007 | US20070128192 Human antibody molecules for il-13 |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | CA2670801A1 Compositions and methods of using sirna to knockdown gene expression and to improve solid organ and cell transplantation |
| 06/07/2007 | CA2631760A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |